Concepedia

Author

Miho Hiraki

Shimane University

Also Known As

Miho Hiraki

28

Publications

371

Citations

9

H-Index

21

Concepts

All Affiliations

Shimane UniversitySan Francisco VA Medical CenterUniversity of California, San FranciscoThe University of OsakaYonsei University
MH

About

Miho Hiraki is an author at Shimane University specializing in tumor biology, medicine, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

30

2

Cell Biology

2

2

30

3

Pathology

2

2

30

4

Health Sciences

1

1

10

5

Natural Sciences

1

1

20

Miho Hiraki

×

8

Publications

344

Citations

8

H-Index

YearCitations

Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma

Yozo Mitsui, Hiroaki Shiina, Taku Kato,

Molecular Cancer Research

2017

90

Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition

Hiroki Tamaki, Nanae Harashima, Miho Hiraki,

Oncotarget

2014

80

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma

Yozo Mitsui, Inik Chang, Shinichiro Fukuhara,

BMC Cancer

2015

54

Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones

Shanshan Cai, Katsumasa Sato, Toshiaki Shimizu,

Journal of Antimicrobial Chemotherapy

2005

49

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways

Yozo Mitsui, Hiroshi Hirata, Naoko Arichi,

Oncotarget

2015

26

Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor

Yozo Mitsui, Hiroaki Yasumoto, Taichi Nagami,

Oncotarget

2014

20

Versican is a potential therapeutic target in docetaxel-resistant prostate cancer

Naoko Arichi, Yozo Mitsui, Miho Hiraki,

Oncoscience

2015

15

Overexpression of bone morphogenetic protein 2 through aberrant canonical Wnt/β-catenin signaling pathway plays an important role in heterotopic ossification of adrenal myelolipoma

Yozo Mitsui, Hiroaki Yasumoto, Miho Hiraki,

Canadian Urological Association Journal

2014

10

Page 1